Köksal N, Altinkaya N, Perk Y
Faculty of Medicine, Uludağ University, Bursa, Turkey.
Acta Paediatr. 1996 Dec;85(12):1501-2. doi: 10.1111/j.1651-2227.1996.tb13961.x.
Following immunization with hepatitis B vaccine, 39 infants were followed prospectively for hepatitis B surface antigen (HBsAg). A total of 69.2% of the infants tested positive for antigenemia at least once. Antigenemia was identified most often at 2-3 days (43.5%) and 5-6 days (43.5%) after immunization. The longest documented duration of antigenemia was 21 days. In all cases the antigenemia was transient and cleared by 28th day post-vaccination.